Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

Published:2019-06 Issue:23 Volume:73 Page:2961-2970
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Charytan David M.,Sabatine Marc S.,Pedersen Terje R.,Im KyungAh,Park Jeong-Gun,Pineda Armando Lira,Wasserman Scott M.,Deedwania Prakash,Olsson Anders G.,Sever Peter S.,Keech Anthony C.,Giugliano Robert P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

2. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction;Anavekar;N Engl J Med,2004

3. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis;Wanner;N Engl J Med,2005

4. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial;Baigent;Lancet,2011

5. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis;Fellstrom;N Engl J Med,2009

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes;Journal of Clinical Medicine;2024-08-25

2. Association between PCSK9 inhibitors and acute kidney injury: a pharmacovigilance study;Frontiers in Pharmacology;2024-08-01

3. Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease;Mayo Clinic Proceedings;2024-08

4. Is coronary artery disease screening by imaging in patients with chronic kidney disease necessary?;Archives of Cardiovascular Diseases;2024-08

5. Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024;BMC Nephrology;2024-07-06